Abstract
Infantile hemangioma (IH) is one of the most common vascular tumors of childhood. Long noncoding RNAs (lncRNAs) play a critical role in angiogenesis, but their involvement in hemangioma remains unknown. This study aimed to assess the expression profiles of lncRNAs in IH and adjacent normal tissue samples, exploring the biological functions of lncRNAs as well as their involvement in IH pathogenesis. The lncRNA expression profiles were determined by lncRNA microarrays. A total of 1259 and 857 lncRNAs were upregulated and downregulated in IH, respectively, at a fold change cutoff of 2.0 (p < 0.05); in addition, 1469 and 1184 messenger RNAs (mRNAs) were upregulated and downregulated, respectively (fold change cutoff of 2.0; p < 0.05). A total of 292 differentially expressed mRNAs were targeted by the lncRNAs with altered expression in hemangioma, including 228 and 64 upregulated and downregulated, respectively (cutoff of 2.0, p < 0.05). Gene ontology (GO) analyses revealed several angiogenesis-related pathways. An lncRNA-mRNA co-expression network for differentially expressed lncRNAs revealed significant associations of the lncRNAs MEG3, MEG8, FENDRR, and Linc00152 with their related mRNAs. The validation results of nine differentially expressed lncRNAs (MALAT1, MEG3, MEG8, p29066, p33867, FENDRR, Linc00152, p44557_v4, p8683) as well as two mRNAs (FOXF1, EGFL7) indicated that the microarray data correlated well with the QPCR results. Interestingly, MALAT1 knockdown induced apoptosis and S-phase cell cycle arrest in human umbilical vein endothelial cells (HUVECs). Overall, this study revealed the lncRNA expression profile of IH and that lncRNAs likely regulate several genes with important roles in angiogenesis.
Similar content being viewed by others
References
Hoornweg MJ, Smeulders MJ, van der Horst CM. Prevalence and characteristics of haemangiomas in young children. Ned Tijdschr Geneeskd. 2005;149(44):2455–8.
Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol. 2008;25(2):168–73. doi:10.1111/j.1525-1470.2008.00626.x.
Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011;25(11):1245–53.
Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138(12):1567–76.
Dickison P, Christou E, Wargon OA. Prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol. 2011;28(6):663–9. doi:10.1111/j.1525-1470.2011.01568.x.
Bauland CG, Smit JM, Bartelink LR, Zondervan HA, Spauwen PH. Hemangioma in the newborn: increased incidence after chorionic villus sampling. Prenat Diagn. 2010;30(10):913–7. doi:10.1002/pd.2562.
Burton BK, Schulz CJ, Angle B, Burd LI. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS. Prenat Diagn. 1995;15(3):209–14.
Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007;150(3):291–4. doi:10.1016/j.jpeds.2006.12.003.
Selmin A, Foltran F, Chiarelli S, Ciullo R, Gregori D. An epidemiological study investigating the relationship between chorangioma and infantile hemangioma. Pathol Res Pract. 2014;210(9):548–53. doi:10.1016/j.prp.2014.04.007.
Munden A, Butschek R, Tom WL, Marshall JS, Poeltler DM, Krohne SE, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014;170(4):907–13. doi:10.1111/bjd.12804.
Itinteang T, Withers AH, Davis PF, Tan ST. Biology of infantile hemangioma. Front Surg. 2014;1:38. doi:10.3389/fsurg.2014.00038.
Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis. 2009;12(2):197–207. doi:10.1007/s10456-009-9148-2.
Huang L, Nakayama H, Klagsbrun M, Mulliken JB, Bischoff J. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells. 2015;33(1):133–45.
Xu D, TM O, Shartava A, Fowles TC, Yang J, Fink LM, et al. Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model. J Hematol Oncol. 2011;4:54. doi:10.1186/1756-8722-4-54.
Greenberger S, Bischoff J. Pathogenesis of infantile haemangioma. Br J Dermatol. 2013;169(1):12–9. doi:10.1111/bjd.12435.
Przewratil P, Sitkiewicz A, Andrzejewska E. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth. Cytokine. 2010;49(2):141–7. doi:10.1016/j.cyto.2009.11.012.
Chen XD, Ma G, Huang JL, Chen H, Jin YB, Ye XX, et al. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy. Pediatr Dermatol. 2013;30(5):549–53. doi:10.1111/pde.12192.
Zou HX, Jia J, Zhang WF, Sun ZJ, Zhao YF. Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma. Cardiovasc Pathol. 2013;22(3):203–10. doi:10.1016/j.carpath.2012.10.001.
Jiang C, Lin X, Hu X, Chen H, Jin Y, Ma G, et al. Angiogenin: a potential serum marker of infantile hemangioma revealed by cDNA microarray analysis. Plast Reconstr Surg. 2014;134(2):231e–9e. doi:10.1097/prs.0000000000000367.
Stiles JM, Rowntree RK, Amaya C, Diaz D, Kokta V, Mitchell DC, et al. Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells. Vascular. Cell. 2013;5(1):6.
Calicchio M, Collins T. Hp. identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling. Am J Pathol. 2009;174(5):1638–49.
Esteller M, Non-coding RNA. In human disease. Nat Rev Genet. 2011;12(12):861–74. doi:10.1038/nrg3074.
Michalik KM, You X, Manavski Y, Doddaballapur A, Zornig M, Braun T, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014;114(9):1389–97. doi:10.1161/CIRCRESAHA.114.303265.
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis. 2014;5:e1506. doi:10.1038/cddis.2014.466.
Puthanveetil P, Chen S, Feng B, Gautam A, Chakrabarti S. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med. 2015;19(6):1418–25.
Gordon FE, Nutt CL, Cheunsuchon P, Nakayama Y, Provencher KA, Rice KA, et al. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology. 2010;151(6):2443–52. doi:10.1210/en.2009-1151.
Yuan SX, Yang F, Yang Y, Tao QF, Zhang J, Huang G, et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients’ poor recurrence-free survival after hepatectomy. Hepatology. 2012;56(6):2231–41. doi:10.1002/hep.25895.
Lu Z, Xiao Z, Liu F, Cui M, Li W, Yang Z et al. Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget. 2015. doi:10.18632/oncotarget.6280.
Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai Y, et al. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. J Neurosurg. 2015:1–8. doi:10.3171/2014.12.jns1426.
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S, et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res. 2011;39(Web Server issue):W316–22. doi:10.1093/nar/gkr483.
Jia H, Osak M, Bogu GK, Stanton LW, Johnson R, Lipovich L. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA. 2010;16(8):1478–87. doi:10.1261/rna.1951310.
Takeuchi K, Yanai R, Kumase F, Morizane Y, Suzuki J, Kayama M, et al. EGF-like-domain-7 is required for VEGF-induced Akt/ERK activation and vascular tube formation in an ex vivo angiogenesis assay. PLoS One. 2014;9(3):e91849. doi:10.1371/journal.pone.0091849.
Gu T, He H, Han Z, Zeng T, Huang Z, Liu Q, et al. Expression of macro non-coding RNAs Meg8 and Irm in mouse embryonic development. Acta Histochem. 2012;114(4):392–9. doi:10.1016/j.acthis.2011.07.009.
Grote P, Wittler L, Hendrix D, Koch F, Wahrisch S, Beisaw A, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013;24(2):206–14. doi:10.1016/j.devcel.2012.12.012.
Ren X, Ustiyan V, Pradhan A, Cai Y, Havrilak JA, Bolte CS, et al. FOXF1 transcription factor is required for formation of embryonic vasculature by regulating VEGF signaling in endothelial cells. Circ Res. 2014;115(8):709–20. doi:10.1161/circresaha.115.304382.
Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G et al. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget. 2015. doi:10.18632/oncotarget.5970
Zhou J, Zhi X, Wang L, Wang W, Li Z, Tang J, et al. Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway. J Exp Clin Cancer Res. 2015;34(1):135. doi:10.1186/s13046-015-0250-6.
Yang SL, Wu C, Xiong ZF, Fang X. Progress on hypoxia-inducible factor-3: its structure, gene regulation and biological function (review. Mol Med Rep. 2015;12(2):2411–6. doi:10.3892/mmr.2015.3689.
Kanno T, Kamba T, Yamasaki T, Shibasaki N, Saito R, Terada N, et al. JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma. Oncogene. 2012;31(25):3098–110.
Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC. Diminished expression of C/EBPα in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPα in carcinoma cells inhibits proliferation. Cancer Res. 2005;65(3):861–7.
Al Hawas R, Ren Q, Ye S, Karim ZA, Filipovich AH, Whiteheart SW. Munc18b/STXBP2 is required for platelet secretion. Blood. 2012;120(12):2493–500. doi:10.1182/blood-2012-05-430629.
Jenjaroenpun P, Kremenska Y, Nair VM, Kremenskoy M, Joseph B, Kurochkin IV. Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing. Peer J. 2013;1:e201. doi:10.7717/peerj.201.
Wang L, LF W, Lu X, Mo XB, Tang ZX, Lei SF, et al. Integrated analyses of gene expression profiles digs out common markers for rheumatic diseases. PLoS One. 2015;10(9):e0137522. doi:10.1371/journal.pone.0137522.
Grote P, Herrmann BG. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis. RNA Biol. 2013;10(10):1579–85. doi:10.4161/rna.26165.
Sauvageau M, Goff LA, Lodato S, Bonev B, Groff AF, Gerhardinger C, et al. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife. 2013;2:e01749. doi:10.7554/eLife.01749.
Li L, Feng T, Lian Y, Zhang G, Garen A, Song X. Role of human noncoding RNAs in the control of tumorigenesis. Proc Natl Acad Sci. 2009;106(31):12956–61.
Gutschner T, Hämmerle M, Eißmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180–9.
Yang L, Lin C, Liu W, Zhang J, Ohgi KA, Grinstein JD, et al. ncRNA-and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell. 2011;147(4):773–88.
Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013;9(3):e1003368. doi:10.1371/journal.pgen.1003368.
Watts R, Ghozlan M, Hughey CC, Johnsen VL, Shearer J, Hittel DS. Myostatin inhibits proliferation and insulin-stimulated glucose uptake in mouse liver cells. Biochem Cell Biol. 2014;92(3):226–34. doi:10.1139/bcb-2014-0004.
Wang X, Li M, Wang Z, Han S, Tang X, Ge Y, et al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem. 2015;290(7):3925–35. doi:10.1074/jbc.M114.596866.
Cheunsuchon P, Zhou Y, Zhang X, Lee H, Chen W, Nakayama Y, et al. Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol. 2011;179(4):2120–30. doi:10.1016/j.ajpath.2011.07.002.
De Cecco L, Negri T, Brich S, Mauro V, Bozzi F, Dagrada G, et al. Identification of a gene expression driven progression pathway in myxoid liposarcoma. Oncotarget. 2014;5(15):5965–77. doi:10.18632/oncotarget.2023.
Astorga J, Carlsson P. Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. Development. 2007;134(20):3753–61. doi:10.1242/dev.004432.
Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li YJ, et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 2015;116(7):1143–56. doi:10.1161/CIRCRESAHA.116.305510.
Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan G, et al. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget. 2016;7(12):14429–40. doi:10.18632/oncotarget.7418.
Guo X, Yang Z, Zhi Q, Wang D, Guo L, Li G, et al. Long noncoding RNA OR3A4 promotes metastasis and tumorigenicity in gastric cancer. Oncotarget. 2016. doi:10.18632/oncotarget.7217.
WM F, YF L, BG H, Liang WC, Zhu X, Yang HD, et al. Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways. Oncotarget. 2016;7(4):4712–23. doi:10.18632/oncotarget.6731.
Schultz B, Yao X, Deng Y, Waner M, Spock C, Tom L, et al. A common polymorphism within the IGF2 imprinting control region is associated with parent of origin specific effects in infantile hemangiomas. PLoS One. 2015;10(10):e0113168. doi:10.1371/journal.pone.0113168.
Seo S, Singh HP, Lacal PM, Sasman A, Fatima A, Liu T, et al. Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth. Proc Natl Acad Sci. 2012;109(6):2015–20.
Amin DN, Bielenberg DR, Lifshits E, Heymach JV, Klagsbrun M, Targeting EGFR. Activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells. Microvasc Res. 2008;76(1):15–22.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (Grant No. 81171828).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was supported by the National Natural Science Foundation of China (Grant No. 81171828).
Conflicts of interest
None
Ethical approval
This study was approved by the ethics committee of Shandong Provincial Hospital, China (No. 2014-011).
Informed consent
Patient guardians provided verbal and written informed consent.
Electronic supplementary material
ESM 1
(DOCX 18 kb)
Supplementary Figure 1
Hierarchical clustering analysis of 2116 differentially expressed long noncoding RNAs (lncRNAs) and 2653 differentially expressed mRNAs. Red and green indicate increased and reduced expression levels, respectively. In the heat map, columns represent samples and rows are the various genes. Scale of expression level is shown on the horizontal bar. (GIF 352 kb)
Rights and permissions
About this article
Cite this article
Liu, X., Lv, R., Zhang, L. et al. Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis. Tumor Biol. 37, 15977–15987 (2016). https://doi.org/10.1007/s13277-016-5434-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-016-5434-y